Filing Flows › iSpecimen (ISPC) › Q2 2026 › vs Q1 2026
iSpecimen (ISPC) Q2 2026 vs Q1 2026 (quarter over quarter)
iSpecimen's revenue fell $4K (-3%) from $156K in Q1 2026 to $152K in Q2 2026. The biggest changes: Product −$9K (-7%); Shipping and Handling +$5K (+23%).
iSpecimen, Q2 2026: revenue $152K (-79% year over year), operating margin -897.1%, net loss $1.4M, operating cash flow −$690K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Product | $125K | $134K | −$9K | -7% |
| Shipping and Handling | $27K | $22K | $5K | +23% |
| Revenue | $152K | $156K | −$4K | -3% |
| Net loss | $1.4M | $2.3M | −$912K | -40% |
| Costs & expenses | $1.5M | $2.7M | −$1.2M | -44% |
| Operating costs | $1.5M | $2.7M | −$1.2M | -44% |
| Cost of revenue | $83K | $84K | −$1K | -1% |
| Sales & marketing | $544K | $1.5M | −$998K | -65% |
| General & admin | $443K | $680K | −$238K | -35% |
| Other operating costs | $445K | $387K | $57K | +15% |
| Operating cash sources | $1.4M | $2.3M | −$912K | -40% |
| Depreciation & amortization | $201K | $136K | $66K | +48% |
| Share-based compensation | $153 | $1K | −$1K | -85% |
| Working capital & other | $472K | −$1.2M | $1.7M | — |
| Cash used in operations | $690K | $3.4M | −$2.7M | -79% |
| Net loss absorbed | $1.4M | $2.3M | −$912K | -40% |
Questions
How much did iSpecimen's revenue grow quarter over quarter in Q2 2026?
iSpecimen's revenue fell $4K (-3%) from $156K in Q1 2026 to $152K in Q2 2026.
What drove iSpecimen's revenue change in Q2 2026?
Product −$9K (-7%); Shipping and Handling +$5K (+23%).